ArcherDX
Biotechnology firm specializing in cancer research.
Launch date
Employees
Market cap
-
Enterprise valuation
€1.3b (Public information from Oct 2020)
Boulder Colorado (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$35.0m | Series A | ||
$60.0m | Series B | ||
* | $55.0m | Series C | |
$1.4b Valuation: $1.4b | Acquisition | ||
* | $48.0m | Acquisition | |
| Total Funding | €137m | ||
Related Content
Recent News about ArcherDX
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.